Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06432543
Other study ID # OMU 2023-132
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date June 1, 2024
Est. completion date December 31, 2028

Study information

Verified date May 2024
Source Osaka Metropolitan University
Contact Yukihide Minoda, MD, PhD
Phone 81-6-6645-3851
Email yminoda@omu.ac.jp
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Purpose of research The purpose of this study was to demonstrate that polyethylene (Vitamin E-containing polyethylene), a newly introduced biomaterial for tibial inserts in hip replacement surgery and widely used clinically, but whose mid- to long-term clinical results are still unknown, is superior to conventional polyethylene in vivo. The aim of this project is to conduct an international multi-center joint research study to determine whether polyethylene wear debris production can be reduced in the future, using an in vivo polyethylene wear debris analysis method that the investigators developed as a method that can provide early feedback.


Description:

Research method In this study, the investigators conducted the following steps to determine the in vivo wear particles (number, size, and morphology) of conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose mid- to long-term results have not yet been clarified. Clarifying the difference. Target of this research In this study, the investigators will focus on patients undergoing revision hip arthroplasty as a routine medical treatment. First total joint replacement - 30 patients using polyethylene containing Vitamin E - 30 patients using conventional polyethylene (no high cross-linking) - 30 patients using conventional polyethylene (with high cross-linking) Accumulation of periarticular tissue In this study, the investigators will focus on patients undergoing revision hip arthroplasty as a routine medical treatment. The test will be conducted after obtaining approval from the ethics committee at each facility and obtaining informed consent. The pericapsular tissue, which is removed during surgery and usually discarded, is obtained and fixed in formalin fixative. The tissue will be transported to the Department of Orthopedic Surgery, Osaka Public University Graduate School of Medicine for analysis. International transportation of tissues requires outsourcing to specialized companies with experience in transporting tissues from overseas. Isolation of polyethylene wear debris The collected tissue around the joint capsule is immersed in 5Mol sodium hydroxide at 65°C for 1 hour to decompose the protein. Make a sucrose layer (5, 10, 20%) in a 14ml tube (14PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the dissolved solution, and place in an ultracentrifuge (CP100a, P28S1014 rotor, Hitachi Koki). Ultracentrifuge at 28,000 rpm [103,7009g] for 3 hours at 4°C. Prepare an isopropanol layer (0.90 and 0.96 g/mL) in a 40 ml tube (40PA tube, Hitachi Koki Co, Ltd, Tokyo, Japan), add the upper layer of sucrose layer, and centrifuge at 28,000 rpm (103,7009 g) and perform ultracentrifugation at 4°C for 1 hour. The isopropanol interlayer is collected to isolate polyethylene wear debris. Analysis of polyethylene wear debris The isopropanol interlayer is filtered through a 0.1 μm polycarbonate filter (VCTP 013-00, Millipore Corporation, Bedford, MA). Dry the polycarbonate filter, fix it on an aluminum pedestal (M4, Nisshin EM Co, Ltd, Tokyo, Japan), and apply platinum coating (E-1030 ion sputter, Hitachi Science Systems Ltd, Tokyo, Japan). Observe the polyethylene wear particles on the polycarbonate filter using a scanning electron microscope (S4700SI, Hitachi Ltd, Tokyo, Japan), and analyze the following items using an image analyzer (Mac Scope, Mitani Co, Tokyo, Japan). - Number of polyethylene wear particles (number per 1g of tissue) - Size (Equivalent circle diameter [μm]) - Shape (aspect ratio, roundness) Comparison of iv vivo polyethylene wear powder morphology depending on polyethylene material The number, size, and form of polyethylene wear debris will be compared between conventional polyethylene, whose long-term results have already been clarified, and vitamin E-containing polyethylene, whose medium- to long-term results have not yet been clarified. The investigators also investigated factors that affect polyethylene wear in vivo (age, height, weight, period from initial surgery to revision surgery, hip joint range of motion, hip prosthesis clinical score [Hip dysfunction and Osteoarthritis Outcome Score for Joint Replacement [HOOS Jr], Harris Hip Score, University of California Los Angeles [UCLA] activity score]).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 90
Est. completion date December 31, 2028
Est. primary completion date December 31, 2027
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: 1. Patients undergoing revision hip arthroplasty within the study period 2. Patients over 20 years old 3. Patients who have received a sufficient explanation, have sufficient understanding, and have given their free written consent. 4. Patients who have passed 2 years or more since their first total hip arthroplasty Exclusion Criteria: 1. Patients who are judged to be unsuitable as research subjects by the research physician

Study Design


Related Conditions & MeSH terms


Intervention

Device:
polyethylene
No intervention as this is an observational study

Locations

Country Name City State
n/a

Sponsors (4)

Lead Sponsor Collaborator
Osaka Metropolitan University Hospital for Special Surgery, New York, Istituto Ortopedico Rizzoli, Mayo Clinic

References & Publications (3)

Hata K, Minoda Y, Ikebuchi M, Mizokawa S, Ohta Y, Miyazaki N, Miyake Y, Nakamura H. In vivo wear particles of remelted highly crosslinked polyethylene after total hip arthroplasty: report of four cases. J Mater Sci Mater Med. 2015 Mar;26(3):133. doi: 10.1 — View Citation

Iwakiri K, Iwaki H, Kobayashi A, Minoda Y, Kagiyama H, Kadoya Y, Takaoka K. Characteristics of Hylamer polyethylene particles isolated from peri-prosthetic tissues of failed cemented total hip arthroplasties. J Biomed Mater Res B Appl Biomater. 2008 Apr;8 — View Citation

Minoda Y, Kobayashi A, Sakawa A, Aihara M, Tada K, Sugama R, Iwakiri K, Ohashi H, Takaoka K. Wear particle analysis of highly crosslinked polyethylene isolated from a failed total hip arthroplasty. J Biomed Mater Res B Appl Biomater. 2008 Aug;86(2):501-5. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Number of polyethylene wear particles counts / g (tissue sample) When tissue sample was collected during THA revision surgery
Primary Equivalent circle diameter of polyethylene wear particles equivalent circle diameter [?] When tissue sample was collected during THA revision surgery
Primary Aspect ratio of polyethylene wear particles aspect ratio When tissue sample was collected during THA revision surgery
Primary Roundness of polyethylene wear particles roundness When tissue sample was collected during THA revision surgery
Secondary Body mass index kg/m2 When tissue sample was collected during THA revision surgery
Secondary Hip joint flexion angle Degrees When tissue sample was collected during THA revision surgery
Secondary Hip joint exertion angle Degrees When tissue sample was collected during THA revision surgery
Secondary Hip joint adduction angle Degrees When tissue sample was collected during THA revision surgery
Secondary Hip joint abduction angle Degrees When tissue sample was collected during THA revision surgery
Secondary Hip dysfunction and Osteoarthritis Outcome. Score for Joint Replacement 0(worse)-100(best) When tissue sample was collected during THA revision surgery
Secondary Harris Hip Score 0(worse)-100(best) When tissue sample was collected during THA revision surgery
Secondary University of California at Los Angeles activity score 1(worse)-10(best) When tissue sample was collected during THA revision surgery
See also
  Status Clinical Trial Phase
Recruiting NCT05556759 - Anterior Iliopsoas Muscle Space Block Versus Supra-iliac Anterior Quadratus Lumborum Block in Total Hip Arthroplasty N/A
Withdrawn NCT05030688 - Fascia Iliaca Compartment Block and PENG Block for Hip Arthroplasty N/A
Not yet recruiting NCT05015517 - ESP Block vs FIB in Patients Undergoing Hip Arthroplasty N/A
Completed NCT05134207 - The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty N/A
Recruiting NCT04438265 - Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment
Recruiting NCT04229368 - Effect of Vitamin D Status and Repletion on Postoperative Total Joint Arthroplasty Complications N/A
Active, not recruiting NCT05142462 - Post Market Clinical Follow-up of EUROSCUP Fixe Acetabular Cup
Completed NCT06083428 - Erector Spinae vs. PENG Block for Total Hip Arthroplasty Phase 4
Completed NCT05396924 - Rectal Temperature Measurement in Detecting Hypothermia During Hip Arthroscopy N/A
Active, not recruiting NCT05524363 - Assessment of Safety and Performances of HYPE SCS Stem Associated to NOVAE Sunfit TH Acetabular Cup in Hip Arthroplasty
Recruiting NCT06147401 - Comparison of PENG Associated With LFCN Block Versus FICB for Multimodal Analgesic Management in THA N/A
Completed NCT03977454 - Periarticular Injection Versus Peripheral Nerve Block in Total Hip Arthroplasty Phase 2
Recruiting NCT05397145 - Iliopsoas Plane Block vs PENG Block for Hip Arthroplasty N/A
Completed NCT03981354 - Nutritional Status and Its Modifications After Hip Replacement
Recruiting NCT06257160 - Superiority Randomized Controlled Trial of Ultrasound-guided PENG Block Compared to Surgical Infiltration in the Analgesia of Posterior Total Hip Arthroplasty Surgery N/A
Active, not recruiting NCT04995822 - Post Market Clinical Follow-up of EUROSTEM Femoral Stem
Completed NCT04883788 - The Impact of COVID-19 Pandemic on Hip and Knee Replacement
Not yet recruiting NCT06317870 - Pericapsular Nerve Block Versus Intrathecal Morphine for Analgesia After Primary Hip Arthroplasty N/A
Completed NCT03541798 - Comparison of Three Different Sitting Positions for Performing Combined Spinal-Epidural Anesthesia N/A
Completed NCT04306133 - PENG Block Combined to Wound Infiltration for Hip Replacement N/A